Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chang An granules for diarrhea-predominant IBS
CTR20170186Phase 3Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine Yuan Chuang Technology
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Changan Granules in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Shanghai University of Traditional Chinese Medicine Yuan Chuang Technology. Started Mar 2017; status: completed.
02
Drugs
Changan Granules
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20170186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170186.